Portada | Volúmenes anteriores

Ginecología y Obstetricia
© Sociedad Peruana de Obstetricia y Ginecología
 



Ginecol. obstet.  2003; 49 (4) : 257 -258


PREVENCIÓN Y TRATAMIENTO DE OSTEOPOROSIS

Camil Castelo-Branco, Félix Ayala-Peralta, Juan Enrique Blümel.


 

BIBLIOGRAFÍA

  1. Carrasco-Carrasco E, Morote-Martínez A. Osteoporosis y su
    prevención nutricional. JANO 1997; 1290: 41-8.

  2. Messinger-Rapport BJ, Thacker HL. Prevention for the older woman. A practical guide to prevention and treatment of osteoporosis. Geriatrics 2002; 57(4): 16-27.

  3. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. Osteoporosis prevention, diagnosis and therapy. JAMA 2001; 285: 785-95.

  4. Lamibing CL. Osteoporosis prevention, detection and treatment. A mandate for primary care physicians. Postgraduate Med 2000; 107: 37-48.

  5. Saggese G, Baroncelli GI, Bertelloni S. Osteoporosis in children and adolescents: diagnosis, risk factors, and prevention. 1 Pediatr Endocrinol Metab 2001; 14(7): 833-59.

  6. Fleming R, Patrick K. Osteoporosis prevention: pediatricians' knowl-edge, attitudes, and counseling practices. Prev Med 2002; 34(4): 411 21.

  7. Moro-Alvárez, Díaz-Curiel M. Tratamiento preventivo de la osteoporosis primaria. REEMO 2001; 10 (suplemento A): 20-5.

  8. Ribeiro V, Blakeley J, Laryea M. Wornen's knowledge and practices regarding the prevention and treatment of osteoporosis. Health Care Women Int 2000; 21(4): 347-53.

  9. Atkinson SA, Ward WE. Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis. CMAJ 2001; 165(11): 1511-4.

  10. Dowd R. Role of calcium, vitamin D, and other essential nutrients in the prevention and treatment of osteoporosis. Nurs Clin North Am 2001; 36(3): 417-31.

  11. Rapado A. Dieta y osteoporosis, En: Rapado A, Díaz Curiel M, Galindo P, eds. Osteoporosis. Unaguía para profesionales de la salud. Madrid: FHOEMO, 1997:79-89.

  12. Cappuccio FP. Thiazide use and reduced sodium intake for prevention of osteoporosis. JAMA 2001; 285(18): 2323-4.

  13. Nordin BE. Calcium and osteoporosis. Nutrition 1997; 13(7-8): 664-86.

  14. Johnston CC Jr, Miller JZ, Slemenda CW, ReisterTK, Hui S, Christian JC, Peacock M. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992; 327(2): 82-7.

  15. Heaney RP. Nutricional factors in osteoporosis. Ann Rev Nutr 1993; 13: 287-326.

  16. Recker RR, Heaney RP. The effect of milk supplements on calcium metabolism, bone metabolism and calcium balance. Am J Clin Nutr 1985; 41 (2): 254-63.

  17. Gonzalez-Calvil JL, Garcia-Sanchez A, Bellot V, Muñoz-Torres M, Raya Alvaraez E, Salvatierra Rios D. Mineral metabolism, osteoblastic function and bone mass en chronic alcoholism. Alcohol 1993; 28: 571-9.

  18. Girasole G, Giuliani N, Pedrazzoni M, Alfano FS, Gatti C, Campani C, et al. Ethanol inhibits osteoblastogenesis in vitro and in vivo and stimulates the production of IL-6 by osteoblast. En: Papapoulos SE, Lips P, Pols HAP, Johmston CC, Delmas PD, eds. Osteoporosis 1996. World Congress on Osteoporosis. Arristerdam: Elsevier, 1996:49-54.

  19. Peris P, Pares A, Guanabens N, Del Rio L, Pons F, Martinez de Osaba MJ, Monegal A, Caballería J, Rodes J, Munoz-Gomez J. Bone mass
    improves in alcoholics after 2 years of abstinence. J Bone Miner Res 1994; 90 (10): 1607-12.

  20. Holbrook T, Barret-Connor E. A prospective study of alcohol consumption and bone mineral density. BMJ 1993: 306: 1 506-9.

  21. Slemenda W, Hui SL, Longcope C, Johnstob CC. Cigarette smoking, obesity and bone mass. J Bone Miner Res 1989; 4: 737-41.

  22. Krall EA, Dawson-Hughes B. Smoking and bone loss among postmenopausal women. J Bone Miner Res 1991: 6: 331-8.

  23. Cooper C, Atkinson E], Walhner HW, O'Fallon WM, Riggs BI, Judd HL, Melton LJ 3rd. Is caffeine consumption a risk factor for osteoporosis? J Bone Miner Res 1992; 7(4): 465-71.

  24. Kiel DP, Felson DT, Hannan MT, Anderson JJ, Wilson PW. Caffeine and the risk of hip fracture: the Framingham Study. Ann J Epidemiol 1990; 132(4): 675-84.

  25. Hegarty VM, May HM, Khaw KT. Tea drinking and bone mineral density in older women. Am J Clin Nutr 2000; 71(4):1003-7.

  26. Sharkey NA, Willianis NI, Guerin JB. The role of exercise in the prevention and treatment oí osteoporosis and osteoarthritis. Nurs Clin North Am 2000; 35(1): 209-21.

  27. Henderson NK, White CP, Eisman JA. The roles of exercise and fall risk reduction in the prevention of osteoporosis. Endocrinol Metab Clin North Am 1998; 27(2): 369-87.

  28. Hertel KL, Trahiotis MG. Exercise in the prevention and treatment of osteoporosis:the roleof physical therapy and nursing. Nurs Clin North Am 2001; 36(3): 441-53.

  29. Bemben DA. Exercise interventions for osteoporosis prevention in posmenopausal women. J Okla State Med Assoc 1999;-92(2): 66-70.

  30. Sinaki M. Effect of physical activity on bone mass. Curr Opin Rheumatol 1996; 8: 376-83.

  31. Grupo de trabajo de la Sociedad Española de Investigación Ósea y Metabolismo Mineral (SEIOMM). Osteoporosis postmenopáusica. Guía de práctica clínica. Versión resumida. REEM0 2002; 11: 67-78.

  32. Davey DA. Calcium and the prevention and treatment of postmenopausal osteoporosis. S Afr Med J 1997; 87(2): 132-3.

  33. NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. JAMA 1994; 272(24):1942-8.

  34. Peris P. Consumo de calcio y utilización de suplementos de calcio y vitamina D en mujeres posmenopáusicas. Med Clin 1999.113 (1): 36-41.

  35. Murray TM. Prevention and management of osteoporosis: consensus statements frorin the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis. CMAJ 1996; 155(7): 935-9.

  36. Díaz-Curiel M. Osteoporosis de la rnenopausia, prevención y su tratai-niento. En: AEEM (Asociación Española para el Estudio de la Menopausia) eds. Medicina Basada en la Evidencia en Menopausia. Madrid, 2002: 227-44.

  37. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ Long term effects of calcium supplementation en bone loss and fractures in post-menopausal women: A randomized controlled trial. Am J Med 1995; 98: 331-5.

  38. Chevalley T, Rizzoli R, Nydegger V et al. Effects of calcium supplements en femoral bone mineral density and vertebral fracture in vitamine D replete elderly women. Osteoporos Int 1994; 4: 245-52.

  39. Van der Wielen RPJ, Löwik MRH, Van den Berg H, De Groot LCPGM, Haller J, Moreiras 0. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995; 346: 207-10.

  40. González-ClementeJM, Martínez-Osaba MJ, Miñarro A, DelgadoMP, Mauricio D, Ribera F. Hipovitaminosis D: alta prevalencia en ancianos de Barcelona atendidos ambulatoriamente. Factores asociados. Med Clin (Barc) 1999; 113: 641-5.

  41. José Sanfélix-Genovés J, Palop-Larrea V, Martínez-Mir I, Farga-Martí C. Med Clin (Barc) 2000; 114: 793-4.

  42. Rodríguez-Martinez MA, Garcia-Cohen EC. Role of Ca(2+) and vitamin D in the prevention and treatment of osteoporosis. Pharmacol Ther 2002; 93(1): 37-49.

  43. Feit JM. Calcium and vitaimin D supplements for elderly patients. J Fam Pract 1997; 45(6): 471-2.

  44. Dhesi JK, jackson SH, Allai.n T. Osteoporosis and the role of vitamin D and calcium. Age Ageing 2001; 30(1): 88-9.

  45. O´Brien KO. Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women. Nutr Rev 1998; 56(5 Pt 1): 148-50.

  46. Tiyard MW, Spears GFS,Thomson J, Dovey S.Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992; 326: 357-62.

  47. Nordin BE, Morris HA. Osteoporosis and vitamin D. J Cell Biochem 1992; 49(1):19-25.

  48. Chapuy MC, ARlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994; 308: 1081-2.

  49. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE Effect of calcium and vitamin D supplementation on bone density in rnen and wornen 65 years of age or older. N Engl J Med 1997; 337: 670-6.

  50. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter L.M. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996; 124(4): 400-6.

  51. Holbrook TL, Barrett-Connor E. The association of lifetime weight and weight control patterns with bone mineral density in an adult community. Bone Miner 1993; 20(2): 141-9.

  52. Murillo-Uribe A, Carrranza-Lira S, Martinez-Trejo, Santos-Gonzalez J. influence of weight and body fat distribution on bone density in postimenopausal women. Int J Fertil Womens Med 2000; 45: 225-31.

  53. Karo I, Toniolo P, Zeleniuch-Jacquotte A, Shore RE, Koening KL, Akhmedkhanow A, Riboli E. Diet, smoking and anthropometric indices and postmenopausal bone fractures: a prospective study. Int J Epidemiol 2000; 29: 85-92.

  54. Cappuccion FP, Meilahn E, Zimuda JM, Cauley JA. High blood pressure and bone mineral loss in elderley white women: a prospective study. Study of osteoporotic fractures research group. Lancet 1999; 354: 971-5.

  55. Christiansen C, Christensen MS, Transbol I. Bone mass after withdrawal of oestrogen replacement. Lancet 1981; 1 (8228): 1053-4.

  56. Arreníbrecht S, Boermans AJ. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial. Osteoporos Int 2OO2; 13(2): 176-83.

  57. Weiss SR, Ellman H, Dolker M. A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transclermal Estradiol investigator Group. Obstet Gynecol 1999; 94(3): 330-6.

  58. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. BMC Musculoskelet Disord 2001; 2: 1814-7.

  59. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 2001; 285(22): 2891-7.

  60. Greendale GA, Espeland M, Slone S, et al. Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study. Arch Intern Med 2002; 162: 665-72.

  61. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-33.

  62. Thiebaud D, Bigler JM, et al. A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone. Climacteric 1998; 3: 202-10.

  63. Tinetti ME, Speechley M. Prevention offalls among the elderly. N Engl J Med 1989; 320: 1055-9.

  64. Gryfe CL, Amies A, Ashley MJ. A longitudinal study of falls in an elderly population 1: Incidenceand morbility. Age Ageing 1977; 6: 20110.

  65. Lauritzen JB, Petersen MM, Lund B. Effect of external hip protectors on hip fractures. Lancet 1993; 341: 11-3.

 

 

Texto completo | Tabla de contenido

     

Volúmenes anteriores | Listado por Títulos


UNMSM | Sistema de Bibliotecas | Biblioteca Digital

© 1997-2008 UNMSM. Oficina General del Sistema de Bibliotecas y Biblioteca Central
Comentarios y/o sugerencia : sisbiblio@unmsm.edu.pe
Todos los derechos reservados
Lima - Perú